These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9302173

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of a mutant androgen receptor offers a treatment modality in a patient with partial androgen insensitivity syndrome.
    Radmayr C, Culig Z, Hobisch A, Corvin S, Bartsch G, Klocker H.
    Eur Urol; 1998; 33(2):222-6. PubMed ID: 9519369
    [Abstract] [Full Text] [Related]

  • 3. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
    Quigley CA, Tan JA, He B, Zhou ZX, Mebarki F, Morel Y, Forest MG, Chatelain P, Ritzén EM, French FS, Wilson EM.
    Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Partial androgen insensitivity: the Reifenstein syndrome revisited.
    Amrhein JA, Klingensmith GJ, Walsh PC, McKusick VA, Migeon CJ.
    N Engl J Med; 1977 Aug 18; 297(7):350-6. PubMed ID: 876326
    [Abstract] [Full Text] [Related]

  • 6. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
    Jääskeläinen J, Mongan NP, Harland S, Hughes IA.
    Hum Mutat; 2006 Mar 18; 27(3):291. PubMed ID: 16470553
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
    Tadokoro R, Bunch T, Schwabe JW, Hughes IA, Murphy JC.
    Clin Endocrinol (Oxf); 2009 Aug 18; 71(2):253-60. PubMed ID: 19178528
    [Abstract] [Full Text] [Related]

  • 8. Ala 586 Asp mutation in androgen receptor disrupts transactivation function without affecting androgen binding.
    Rajender S, Gupta NJ, Chakrabarty B, Singh L, Thangaraj K.
    Fertil Steril; 2009 Mar 18; 91(3):933.e23-8. PubMed ID: 19062009
    [Abstract] [Full Text] [Related]

  • 9. In-vitro characterization of androgen receptor mutations associated with complete androgen insensitivity syndrome reveals distinct functional deficits.
    Werner R, Zhan J, Gesing J, Struve D, Hiort O.
    Sex Dev; 2008 Mar 18; 2(2):73-83. PubMed ID: 18577874
    [Abstract] [Full Text] [Related]

  • 10. Novel androgen receptor gene mutations in Australian patients with complete androgen insensitivity syndrome.
    MacLean HE, Ball EM, Rekaris G, Warne GL, Zajac JD.
    Hum Mutat; 2004 Mar 18; 23(3):287. PubMed ID: 14974091
    [Abstract] [Full Text] [Related]

  • 11. The clinical and molecular spectrum of androgen insensitivity syndromes.
    Hiort O, Sinnecker GH, Holterhus PM, Nitsche EM, Kruse K.
    Am J Med Genet; 1996 May 03; 63(1):218-22. PubMed ID: 8723113
    [Abstract] [Full Text] [Related]

  • 12. Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome.
    Raicu F, Giuliani R, Gatta V, Palka C, Franchi PG, Lelli-Chiesa P, Tumini S, Stuppia L.
    Asian J Androl; 2008 Jul 03; 10(4):687-91. PubMed ID: 18097502
    [Abstract] [Full Text] [Related]

  • 13. Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome.
    Chávez B, Méndez JP, Ulloa-Aguirre A, Larrea F, Vilchis F.
    J Hum Genet; 2001 Jul 03; 46(10):560-5. PubMed ID: 11587068
    [Abstract] [Full Text] [Related]

  • 14. [Familial form of partial androgen insensitivity (Reifenstein syndrome): arginine-histidine mutation in position 840 in the androgen receptor].
    Lumbroso S, Lobaccaro JM, Belon C, Amram S, Rodier M, Bringer J, Sultan C.
    C R Seances Soc Biol Fil; 1993 Jul 03; 187(4):508-15. PubMed ID: 8019921
    [Abstract] [Full Text] [Related]

  • 15. [Male pseudohermaphroditism caused by partial insensitivity to androgens. Clinical and biochemical heterogeneity].
    Sultan C, Terraza A, Chabab A, Arlot S, Loire C, Fenart O, Garandeau P, Jean R.
    Arch Fr Pediatr; 1985 Jul 03; 42 Suppl 1():569-74. PubMed ID: 4083989
    [Abstract] [Full Text] [Related]

  • 16. Partial androgen resistance due to a distinctive qualitative defect of the androgen receptor.
    Pinsky L, Kaufman M, Levitsky LL.
    Am J Med Genet; 1987 Jun 03; 27(2):459-66. PubMed ID: 3605226
    [Abstract] [Full Text] [Related]

  • 17. Dihydrotestosterone binding by cultured human fibroblasts. Comparison of cells from control subjects and from patients with hereditary male pseudohermaphroditism due to androgen resistance.
    Griffin JE, Punyashthiti K, Wilson JD.
    J Clin Invest; 1976 May 03; 57(5):1342-51. PubMed ID: 177454
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. L859F mutation in androgen receptor gene results in complete loss of androgen binding to the receptor.
    Rajender S, Singh L, Thangaraj K.
    J Androl; 2007 May 03; 28(5):772-6. PubMed ID: 17522416
    [Abstract] [Full Text] [Related]

  • 20. Androgen receptors and partial androgen insensitivity in male pseudohermaphroditism.
    Sultan C.
    Ann Genet; 1986 May 03; 29(1):5-10. PubMed ID: 3521447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.